The legalization of cannabinoid products and standardizing cannabis-drug developmentin the United States: a brief report

摘要

This brief report covers recent advances in cannabis and cannabinoid regulationand drug approval. The popularity of cannabis and cannabinoid products continues torise, and these products are available for the majority of the population in the UnitedStates to purchase as easily as alcohol. Although many states have approved programs andresearch licenses, these activities and products all remain federally illegal. Thesolution may be for the United States to offer multiple pathways for product approvalthat adapt to the diversity of the products and the needs of the consumer. Multiplepathways for market approval would protect public health, whether the public is usingcannabis and cannabinoids as a medicine, a wellness product, or as a recreationalsubstance.